BNET Industries
Market Cap:$281.1M
Last Fiscal Year Sales:$114.9M
- Public
- IL
Dow Jones Description
Aesthetic Medical Products Mfr & Distr
Number of Employees 300
Peer Companies
NAICS Code Surgical and Medical Instrument Manufacturing: 339112
Recent Events
-
Syneron Medical Slips To Loss In Q3 On Lower Revenues - Update
-
Syneron to Acquire Primaeva
-
Notable Mergers and Acquisitions of the Day 10/16: KFT/SLE/CBY, GE, IOC, ELOS,
-
STOCKS NEWS US-Economic diary for Sept 21
-
Medical Laser Makers Merging
-
Syneron buying Candela in $65 million stock deal
-
Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Candela Corporation
-
Syneron advances following upgrade to 'Outperform'
-
Syneron Medical Ltd. and Candela Corporation to Merge Creating a Leading Global Aesthetic Device Company
-
UPDATE 3-Syneron agrees to buy Candela for $65 mln
-
Syneron Medical reports 2Q loss, revenue drop
-
Syneron to Launch Industry-First Treatment Modality, New Product
News & Analysis
Filter by
syneron medical ltd. - All News and Analysis
Syneron Dental Announces European OEM Agreement
Syneron Dental, a division of Syneron Medical Ltd. (NASDAQ: ELOS), announced that it has signed an OEM agreement with a European company to produce and distribute a dental laser using Syneron's Laser-in-HandpieceTM technology. Details of the agreement have not yet been disclosed. Syneron's novel Laser-in-Handpiece concept, incorporated in its...
Syneron(TM) Partners With the American Academy of Cosmetic Physicians (AAOCP) to Train LipoLite(TM) and Laser LipoSculpture Physicians
SyneronTM Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elosTM combined-energy medical aesthetic devices, today announces a partnership with the American Academy of Cosmetic Physicians AAOCP to support laser liposculpture courses for Syneron's LipoLiteTM laser-assisted liposuction device. The AAOCP is an organization of...
Syneron Reports Fourth Quarter and Full Year 2008 Results
Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elosTM combined-energy medical aesthetic devices, today announced financial results for the fourth quarter and the full year ended December 31st, 2008. Revenues for the fourth quarter of 2008 were $14.2 million, reflecting the direct impact...
Syneron Medical Announces Management Change to Support Strengthening of Syneron's Leadership Position in a Challenging Professional Aesthetic Market
Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elosTM combined-energy medical aesthetic devices, today announced that its Board of Directors has nominated Mr. Lou Scafuri to the CEO position of the company; this nomination is effective immediately. This change in leadership is part of...
Syneron(TM) Unveils Elegant, Portable eMatrix(TM) Skin Resurfacing System
With a simple touch of their finger, physicians now can initiate the best treatment for skin resurfacing patients. SyneronTM Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elosTM combined-energy medical aesthetic devices, today unveils and launches the sleek eMatrixTM treatment system, a portable touch-screen...
Syneron Medical Announces the Establishment of Syneron China
Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elosTM combined-energy medical aesthetic devices, today announced the signing of a joint venture agreement establishing Syneron China. Syneron's partner in Syneron China is the EverCare Medical Group, the largest aesthetic hospital chain in China. Evercare...
Syneron Reports Third Quarter 2008 Revenues of $28.5 Million
Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elosTM combined-energy medical aesthetic devices, today announced its financial results for the third quarter of 2008. Revenues for the third quarter of 2008 were $28.5 million, compared to revenues of $33.1 million in the third...
Syneron Medical Adopts Shareholder Rights Plan
Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elosTM combined-energy medical aesthetic devices, today announced that its board of directors adopted a shareholder rights plan. The shareholder rights plan is designed to protect against any potential future use of coercive or abusive takeover techniques...
Syneron Medical to Present at UBS Global Life Sciences Conference
Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elosTM combined-energy medical aesthetic devices, announced today that Syneron will participate in the UBS Global Life Sciences Conference on Tuesday, September 23, 2008 in New York. Syneron Chairman, Dr. Shimon Eckhouse, will present on...
Syneron Reports Record Second Quarter 2008 Revenues of $38.2 Million and Net Profit of $11.0 Million
Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elosTM combined-energy medical aesthetic devices, today announced its financial results for the second quarter of 2008. Revenues for the second quarter of 2008 were $38.2 million, compared to revenues of $37.5 million in the second...
| Volume | 94,929 |
| Shares Outstanding | 27.5M |
| Market Cap | 281.1M |
| Year High | 12.44 |
| Year Low | 4.55 |
| Earnings Per Share | -1.28 |
| P/E Ratio | N/A |
| Dividend | 0.00 |
| Yield | 0.00 |
Industry Transcripts by Seeking Alpha
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
-
Cytori Therapeutics Q3 2009 Earnings Call Transcript
on Nov 09, 2009about CYTX
-
StoneMor Partners L.P. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 09, 2009about STON
IndustryTop Rated
- Why So Many Insured People Have Big Medical Debts 5 votes
- Physicians Know We Need Reform 4 votes
- Healthcare Roundup: Medical Office Space in Demand, Blues Companies See Lower Income, Two Sides of Health Insurance, and More 3 votes
- Hospital Chain's Turnaround Raises Health Spending 3 votes
- Healthcare Is Still Adding Jobs, Despite Recession 3 votes


